Searched for
MOLBIO DIAGNOSTICS STOCK
Molbio Diagnostics shares rally 30% in 2 days, jump 80% since debut. What lies ahead?Molbio Diagnostics shares have surged nearly 30% in two sessions, extending their post-listing gains to around 80% from the IPO price. The ...- How 90% IPOs in August beat volatile India market to return up to 72% after listingIn August, a majority of newly listed IPOs saw a successful debut, outpacing the broader market. Approximately ninety percent of these list...
- Corporates urge employees to stay alert as H1N1 cases surgeH1N1 cases have increased significantly, and monsoon fevers are at seasonal highs. Companies are issuing safety guidelines and advising emp...
- Strong IPO gains stoke FOMO fears, set grey market abuzzThe unofficial grey market shows increased activity with rising share prices. Recent strong IPO listings have boosted investor confidence a...
- Molbio Diagnostics shares rally 6% after strong debut. What should investors do?Molbio Diagnostics made a strong debut, beating grey market expectations. Experts remain positive on the company’s molecular diagnostics le...
- Lalithaa Jewellery Mart's Rs 1,700-cr IPO opens: GMP signals 15% premium. Should you subscribe?Lalithaa Jewellery Mart IPO GMP: Lalithaa Jewellery Mart has fixed the IPO price band at Rs 190–Rs 201 per share. The Rs 1,700-crore issue ...
- Dhoot Transmission shares make strong debut, list at 38% premium over IPO priceDhoot Transmission Share Price: Dhoot Transmission shares debuted strongly on Dalal Street, listing at a premium. The company plans to use ...
- Molbio Diagnostics shares list at 21% premium over IPO price on BSE, NSEMolbio Diagnostics Share Price: Molbio Diagnostics made a strong stock market debut, listing at a 21.44% premium over its IPO price of Rs 8...
- IPO rush: 5 companies to raise Rs 5,499 crore next week; Shiprocket, 4 others to listIndia’s IPO market enters another busy week, with five companies set to raise Rs 5,499.32 crore between August 17 and 21. Horizon Industria...
- Molbio Diagnostics IPO allotment likely today; GMP at 20% — Here’s how to check statusMolbio Diagnostics IPO allotment is expected on Thursday after the Rs 939.70-crore issue was subscribed 70.26 times. With a grey market pre...
- Molbio Diagnostics IPO Day 3: GMP hints at 17% listing gain, issue booked nearly 5x. Should you participate?Molbio Diagnostics IPO: Point-of-care molecular diagnostics company Molbio Diagnostics saw strong investor response for its IPO, drawing as...
- Molbio Diagnostics IPO Day 2: GMP hits at 17% listing gains. Should you bid?Molbio Diagnostics IPO GMP: The Molbio Diagnostics IPO entered its second day with strong investor interest, as the grey market premium (GM...
- Molbio Diagnostics IPO opens: Should you subscribe for Rs 940 crore issue?Molbio Diagnostics IPO GMP: Market analysts have recommended subscribing to the issue, noting that Molbio Diagnostics’ valuations are broad...
- CXOs log out of unicorns to start up own venturesA large number of top executives have moved from unicorns to Series A and B firms or even down the chain in recent months – a move that ref...
- Cyient DLM shares list at a healthy premium. Should you hold or sell?"We continue to advise allotted investors to book profits, and if anyone wishes to buy, they should wait and watch for the counter as marke...
- Solid Start! Cyient DLM shares list at 52% premium over IPO priceIntegrated electronic manufacturing services provider Cyient DLM made a strong debut on the stock exchanges, with shares listing at a premi...
- Cyient DLM IPO continues to garner strong interest on Day 2; issue subscribed 7.6 timesCyient DLM's initial public offering (IPO) received a strong response as the overall issue was subscribed 7.6 times. The retail category ha...
- Indian companies ready to export coronavirus test kits, target Latin America, Eastern Europe marketsIndia has a manufacturing capacity of 1 billion RT-PCR kits. The country on an average is doing daily testing of 600,000 samples.
Load More
